DOD Biotech PCL (BKK:DOD)
Thailand
· Delayed Price · Currency is THB 1.960
-0.040 (-2.00%)
May 21, 2025, 4:37 PM ICT
DOD Biotech PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -132.39 | -159.33 | 7.19 | -398.33 | 49.79 | 141.25 | Upgrade
|
| Depreciation & Amortization | 51.21 | 59.57 | 72.26 | 62.87 | 67.04 | 76.57 | Upgrade
|
| Other Amortization | 1.1 | 1.1 | 1.2 | 1.64 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.24 | 12.43 | 0.06 | 12.2 | 22.4 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 149.55 | 149.55 | - | - | 106.64 | 128.3 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.54 | -20.95 | -10.05 | 404.64 | -6.14 | 25.6 | Upgrade
|
| Other Operating Activities | 151.22 | 184.65 | 84.49 | -59.66 | 253.32 | 165.01 | Upgrade
|
| Change in Accounts Receivable | 36.73 | 89.58 | -43.44 | -124.57 | -66.1 | -67.33 | Upgrade
|
| Change in Inventory | 42.81 | 14.29 | -8.16 | 48.02 | 54.64 | -130.88 | Upgrade
|
| Change in Accounts Payable | -12.68 | -40.14 | -8.93 | -7.65 | -116.82 | 121.73 | Upgrade
|
| Change in Other Net Operating Assets | -40.54 | -30.44 | -12.07 | -8.46 | 4.12 | 19.76 | Upgrade
|
| Operating Cash Flow | 44.15 | 34.8 | 22.8 | -130.71 | 145 | 322.2 | Upgrade
|
| Operating Cash Flow Growth | 117.90% | 52.65% | - | - | -55.00% | - | Upgrade
|
| Capital Expenditures | -30.29 | -22.49 | -18.07 | -63.29 | -182.93 | -127.55 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.17 | 0.11 | - | 1.42 | 2.35 | 0.18 | Upgrade
|
| Cash Acquisitions | - | - | -71.66 | - | - | - | Upgrade
|
| Divestitures | 4.79 | 4.79 | - | - | - | - | Upgrade
|
| Investment in Securities | -60 | - | - | - | 109.08 | - | Upgrade
|
| Other Investing Activities | -15.59 | -0.17 | -0.06 | -0.25 | -0.86 | -0.2 | Upgrade
|
| Investing Cash Flow | 114.08 | 197.24 | -89.79 | -62.12 | -72.36 | -127.57 | Upgrade
|
| Short-Term Debt Issued | - | - | 9 | 71.7 | - | 37.24 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 22.31 | 16.6 | Upgrade
|
| Total Debt Issued | - | - | 9 | 71.7 | 22.31 | 53.84 | Upgrade
|
| Short-Term Debt Repaid | - | -65.49 | -47.21 | - | -53.39 | - | Upgrade
|
| Long-Term Debt Repaid | - | -6.12 | -25.16 | -31.54 | -44.39 | -44.38 | Upgrade
|
| Total Debt Repaid | -58.44 | -71.6 | -72.36 | -31.54 | -97.78 | -44.38 | Upgrade
|
| Net Debt Issued (Repaid) | -58.44 | -71.6 | -63.36 | 40.16 | -75.47 | 9.46 | Upgrade
|
| Issuance of Common Stock | - | - | 159.4 | 0 | 20.51 | - | Upgrade
|
| Common Dividends Paid | - | - | - | - | - | -143.5 | Upgrade
|
| Other Financing Activities | -3.5 | -5.34 | 8.68 | 21.26 | 1 | - | Upgrade
|
| Financing Cash Flow | -61.94 | -76.94 | 104.72 | 61.42 | -53.96 | -134.04 | Upgrade
|
| Net Cash Flow | 96.29 | 155.1 | 37.72 | -131.41 | 18.68 | 60.58 | Upgrade
|
| Free Cash Flow | 13.87 | 12.31 | 4.72 | -194 | -37.93 | 194.64 | Upgrade
|
| Free Cash Flow Growth | 36.51% | 160.59% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 2.09% | 1.86% | 0.68% | -35.38% | -3.72% | 18.02% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.03 | 0.01 | -0.47 | -0.09 | 0.47 | Upgrade
|
| Cash Interest Paid | - | 0.2 | 5.34 | 4.27 | 4.74 | 9.52 | Upgrade
|
| Cash Income Tax Paid | 26.44 | 26.4 | 4.74 | 3.35 | 43.85 | 19.17 | Upgrade
|
| Levered Free Cash Flow | 51.64 | 108.19 | 4.28 | 271.63 | -2.39 | 140.08 | Upgrade
|
| Unlevered Free Cash Flow | 53.54 | 110.52 | 7.6 | 276.07 | 1.8 | 144.37 | Upgrade
|
| Change in Net Working Capital | -13.11 | -63.31 | 102.69 | -281.97 | 75.62 | 27.67 | Upgrade
|
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.